Brief: Amphastar Pharmaceuticals Q3 EPS USD 0.37
06/11/2025 21:05
Nov 06 (Reuters) - Amphastar Pharmaceuticals Q3 revenue USD 191.84 million vs. IBES estimate USD 187 million. Q3 adjusted net income USD 44.696 million vs. IBES estimate USD 41.9 million Q3 adjusted EPS USD 0.93 vs. IBES estimate USD 0.85 Q3 net income USD 17.35 million
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing